Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | KYNBKyntra Bio, Inc.FY2025 · Dec |
|---|---|
| Revenue | $6.44M |
| Revenue, yoy | −78.3% |
| Net income | $183.45M |
| Net income, yoy | +485.6% |
| Net margin | 2,848.6% |
| Free cash flow | $4.81M |
| FCF margin | -74.7% |
| EPS, diluted | $45.37 |
Add another company.